Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative diseaseClaire E. Le Pichon, Joseph W. Lewcock, William J. Meilandt et al.|Science Translational Medicine|2017Cited by 165
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesDiana W. Shineman, Howard Fillit, Kimberly Scearce‐Levie et al.|Alzheimer s Research & Therapy|2011Cited by 135
Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degenerationChristine D. Pozniak, Joseph W. Lewcock, Arundhati Sengupta Ghosh et al.|The Journal of Experimental Medicine|2013Cited by 107
GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease ModelsJesse E. Hanson, Jorge J. Palop, Keran Ma et al.|Cell Reports|2020Cited by 91
A Death Receptor 6-Amyloid Precursor Protein Pathway Regulates Synapse Density in the Mature CNS But Does Not Contribute to Alzheimer's Disease-Related Pathophysiology in Murine ModelsDara Kallop, Robby M. Weimer, William J. Meilandt et al.|Journal of Neuroscience|2014Cited by 54